Smart Solutions Technologies S.L.

Smart Solutions Technologies S. L. is a healthcare technology company that specializes in innovative textile electrodes for advanced electrocardiogram (ECG) monitoring, enhancing patient care through real-time cardiac health tracking. Founded in 2012 and headquartered in Madrid, Spain, Smart Solutions Technologies S.

L. focuses on developing textile electrodes for ECG monitoring. The company secured funding through a recent deal with CDTI Innovation on November 7, 2023, raising EUR 603,000. Jacobo Crespo is the founder of the company, which has engaged in a total of 5 deals to date.

Nuubo specializes in advanced textile electrodes designed to deliver high-quality electrocardiogram (ECG) signals while ensuring optimal patient comfort. The core product, the Nuubo textile electrode, is engineered for seamless integration into various healthcare settings, enabling real-time monitoring of cardiac health. This innovative technology serves a diverse clientele, including hospitals, clinics, and telemedicine providers, allowing healthcare professionals to monitor patients remotely or during ambulatory settings. The primary end users comprise patients requiring cardiac monitoring, particularly those with chronic heart conditions or those undergoing stress tests.

Nuubo's products are marketed in several international markets, including Europe, North America, and select regions in Asia, catering to a growing demand for wearable health technology that enhances patient care. In the most recent year, 2023, Nuubo reported a revenue of EUR 1,660,174. 90 and an EBITDA of EUR -1,568,274. 20.

The revenue model is driven by the direct sales of textile electrodes and associated monitoring services to healthcare institutions, establishing tailored solutions for cardiac monitoring needs and fostering long-term partnerships with healthcare providers. Following the funding raised in November 2023, Smart Solutions Technologies S. L. plans to expand its presence, particularly in the US market.

The company aims to leverage this funding to further develop its product offerings and potentially introduce new innovations in ECG monitoring technology. The strategic focus will be on enhancing its market reach and establishing partnerships in the healthcare sector, targeting significant growth in the North American region.